Eiger BioPharmaceuticals to Participate in Upcoming Investor Conferences

/PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies...

Related Keywords

Sylvia Wheeler ,Sarah Mathieson ,Prnewswire Eiger Biopharmaceuticals Inc ,Eiger Biopharmaceuticals Inc ,Corporate Affairs ,Nasdaq ,Eiger Biopharmaceuticals ,Nc ,